These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 8647234

  • 1. In vivo analysis of the 'bystander effect': a cytokine cascade.
    Ramesh R, Marrogi AJ, Munshi A, Abboud CN, Freeman SM.
    Exp Hematol; 1996 Jun; 24(7):829-38. PubMed ID: 8647234
    [Abstract] [Full Text] [Related]

  • 2. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R, Munshi A, Abboud CN, Marrogi AJ, Freeman SM.
    Cancer Gene Ther; 1996 Jun; 3(6):373-84. PubMed ID: 8988840
    [Abstract] [Full Text] [Related]

  • 3. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells.
    Freeman SM, Ramesh R, Shastri M, Munshi A, Jensen AK, Marrogi AJ.
    Cancer Lett; 1995 Jun 08; 92(2):167-74. PubMed ID: 7600527
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.
    Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN.
    Cancer Res; 1993 Nov 01; 53(21):5274-83. PubMed ID: 8221662
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [In vitro and in vivo bystander effect of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene].
    Gao G, Huang T, Chen S.
    Zhonghua Wai Ke Za Zhi; 2002 Apr 01; 40(4):301-3. PubMed ID: 12133366
    [Abstract] [Full Text] [Related]

  • 10. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR.
    Ai Zheng; 2005 Aug 01; 24(8):909-14. PubMed ID: 16086864
    [Abstract] [Full Text] [Related]

  • 11. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
    Kong B, Wang W, Liu C, Ma D, Qu X, Jiang J, Yang X, Zhang Y, Jiang S.
    Zhonghua Yi Xue Za Zhi; 2002 Sep 10; 82(17):1207-10. PubMed ID: 12475412
    [Abstract] [Full Text] [Related]

  • 12. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 10; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Jun 10; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 15. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O, Morris JC.
    Cancer Res; 2000 Aug 01; 60(15):4167-74. PubMed ID: 10945625
    [Abstract] [Full Text] [Related]

  • 16. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng, An W, Dai J.
    Cell Res; 1999 Sep 01; 9(3):225-35. PubMed ID: 10520605
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 01; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 18. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J, Chen Y, Li H, Lu Y, Yan Y, Tan X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun 01; 21(3):428-32. PubMed ID: 15250149
    [Abstract] [Full Text] [Related]

  • 19. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R, Schniewind B, Boehle AS, Haye S, Boenicke L, Dohrmann P, Kalthoff H.
    Anticancer Res; 2004 Jun 01; 24(2B):827-31. PubMed ID: 15161034
    [Abstract] [Full Text] [Related]

  • 20. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
    Drescher KM, Whittum-Hudson JA.
    Invest Ophthalmol Vis Sci; 1996 Oct 01; 37(11):2302-12. PubMed ID: 8843914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.